Ruste, Eustaquio, Jr. L.
HRN: 21-40-99 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/06/2022
06/13/2022
IV
4.5
Q6
Dm Foot Right S/p Aka Right
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes